IL46629A - Tablets comprising a 2,4-diaminopyrimidine and a sulphonamide - Google Patents
Tablets comprising a 2,4-diaminopyrimidine and a sulphonamideInfo
- Publication number
- IL46629A IL46629A IL46629A IL4662975A IL46629A IL 46629 A IL46629 A IL 46629A IL 46629 A IL46629 A IL 46629A IL 4662975 A IL4662975 A IL 4662975A IL 46629 A IL46629 A IL 46629A
- Authority
- IL
- Israel
- Prior art keywords
- tablet according
- tablet
- group
- trimethoprim
- sulphonamide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB6758/74A GB1499672A (en) | 1974-02-14 | 1974-02-14 | Tablet formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL46629A0 IL46629A0 (en) | 1975-05-22 |
| IL46629A true IL46629A (en) | 1977-07-31 |
Family
ID=9820242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL46629A IL46629A (en) | 1974-02-14 | 1975-02-13 | Tablets comprising a 2,4-diaminopyrimidine and a sulphonamide |
Country Status (32)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1533243A (en) * | 1975-02-13 | 1978-11-22 | Wellcome Found | Tablet formulation |
| US4115563A (en) * | 1977-03-14 | 1978-09-19 | Sterling Drug Inc. | Pharmaceutical steroid formulation |
| GB1601833A (en) * | 1978-02-06 | 1981-11-04 | Wellcome Found | Antacid formulation |
| HU183408B (en) | 1981-04-28 | 1984-05-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing oral ratard pharmaceutical compositions |
| GB8603964D0 (en) * | 1986-02-18 | 1986-03-26 | Cooper Animal Health Ltd | Compositions |
| US5190760A (en) * | 1989-07-08 | 1993-03-02 | Coopers Animal Health Limited | Solid pharmaceutical composition |
| GB8915716D0 (en) * | 1989-07-08 | 1989-08-31 | Coopers Animal Health | Pharmaceutical compositions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1445983A (en) * | 1972-11-06 | 1976-08-11 | Wellcome Found | Pharmaceutical formulations |
-
1974
- 1974-02-14 GB GB6758/74A patent/GB1499672A/en not_active Expired
-
1975
- 1975-02-13 DE DE2506099A patent/DE2506099C2/de not_active Expired
- 1975-02-13 AT AT108475A patent/AT344915B/de not_active IP Right Cessation
- 1975-02-13 CY CY1052A patent/CY1052A/xx unknown
- 1975-02-13 BE BE153330A patent/BE825496A/xx not_active IP Right Cessation
- 1975-02-13 DK DK52875A patent/DK143247C/da not_active IP Right Cessation
- 1975-02-13 IL IL46629A patent/IL46629A/en unknown
- 1975-02-13 FI FI750398A patent/FI62219C/fi not_active IP Right Cessation
- 1975-02-13 ES ES434688A patent/ES434688A1/es not_active Expired
- 1975-02-13 DD DD184168A patent/DD118228A5/xx unknown
- 1975-02-13 CS CS75927A patent/CS220306B2/cs unknown
- 1975-02-13 ZA ZA00750930A patent/ZA75930B/xx unknown
- 1975-02-13 FR FR7504470A patent/FR2260993B1/fr not_active Expired
- 1975-02-13 IE IE278/75A patent/IE40599B1/xx unknown
- 1975-02-13 HU HU75WE00000519A patent/HU171536B/hu unknown
- 1975-02-13 CA CA219,982A patent/CA980688A/en not_active Expired
- 1975-02-13 JP JP1838875A patent/JPS5545043B2/ja not_active Expired
- 1975-02-13 IN IN270/CAL/75A patent/IN141019B/en unknown
- 1975-02-13 ZM ZM18/75A patent/ZM1875A1/xx unknown
- 1975-02-13 MC MC751136A patent/MC1053A1/xx unknown
- 1975-02-13 AU AU78170/75A patent/AU468465B2/en not_active Expired
- 1975-02-13 PH PH16805A patent/PH14575A/en unknown
- 1975-02-13 CH CH174775A patent/CH618432A5/de not_active IP Right Cessation
- 1975-02-13 NO NO750467A patent/NO146043C/no unknown
- 1975-02-13 SE SE7501595A patent/SE427898B/xx not_active IP Right Cessation
- 1975-02-13 NL NL7501680.A patent/NL157501C/xx not_active IP Right Cessation
- 1975-02-13 LU LU71835A patent/LU71835A1/xx unknown
-
1979
- 1979-05-14 DO DO1979002763A patent/DOP1979002763A/es unknown
- 1979-11-12 GT GT197960431A patent/GT197960431A/es unknown
-
1980
- 1980-03-28 KE KE3038A patent/KE3038A/xx unknown
- 1980-05-01 HK HK239/80A patent/HK23980A/xx unknown
-
1981
- 1981-12-30 MY MY54/81A patent/MY8100054A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4209513A (en) | Tablet formulation | |
| US4562024A (en) | Process for preparing granulate containing poorly compressible medicinally active matter | |
| EP1847260B1 (en) | Solid dispersion preparation | |
| US5087454A (en) | Ibuprofen tablet | |
| IL46629A (en) | Tablets comprising a 2,4-diaminopyrimidine and a sulphonamide | |
| JPH08208484A (ja) | セファクロル含有医薬配合物 | |
| Karpe et al. | Formulation development and evaluation of acyclovir orally disintegrating tablets | |
| Adeleye et al. | Evaluation of cissus gum as binder in a paracetamol tablet formulation | |
| IE42952B1 (en) | Tablet formulation | |
| AU2012327176B2 (en) | Simethicone formulation | |
| IE55579B1 (en) | Processes for preparing tablets by a modified'wet-granulation'technique | |
| Ford et al. | Preparation, properties and ageing of tablets prepared from the chlorpropamide-urea solid dispersion | |
| IE42958B1 (en) | Tablet formulation | |
| Johansson | Influence of the granulation technique and starting material properties on the lubricating effect of granular magnesium stearate | |
| Satyam et al. | Isolation and evaluation of binding property of pappaya starch in diclofenac sodium tablet | |
| JP5576963B2 (ja) | 固体分散体製剤 | |
| Akpabio et al. | Investigating Corchorus olitorius hydrocolloid as a novel matrix former in sustained release delivery of ibuprofen tablet | |
| Subedi | A Research on Comparative Study of Floating Tablets of Theophylline Utilizing Different Techniques | |
| Bukke | EXTENDED RELEASE TABLETS OF LAMIVUDINE: FORMULATION AND IN VITRO EVALUATION | |
| Ologunagba et al. | Formulation and evaluation of dispersible isoniazid tablets for paediatric use: an extemporaneous model formulary application in a resource limited setting | |
| Paramasivam et al. | Formulation and in vitro characterization of tapentadol HCL as immediate release tablets | |
| Vasanthi et al. | Design, formulation and evaluation of fexofenadine hcl immediate release tablets by solid dispersion method using solvent evaporation technique | |
| Jha et al. | Formulation and evaluation of glipizide-loaded fast-dissolving tablets using husk of Plantago ovata as a superdisintegrant | |
| Mohammed et al. | Evaluating the Flow and Release Profiles of Ibuprofen Formulations by Increasing the Binder Concentration | |
| Hackl et al. | Effect of lubricants on the properties of tablets compressed from varied size granules |